ストックスクリーナーアプリを入手
2.21
0.00%
0.00
アフターアワーズ：
2.16
-0.05
-2.26%
In 8 Bio Inc (INAB) 最新ニュース
Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Globe and Mail
Gamma Delta T Cell Therapy Pioneer Adicet Bio to Showcase Latest Developments at Global Investment Conference - Stock Titan
First-in-Class TSLP Antibody Results: Upstream Bio's Verekitug Phase 2 Trial in Nasal Polyps Coming - Stock Titan
Signal strength of KALA BIO Inc. stock in tech scannersJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Is Palisade Bio Inc. trending in predictive chart modelsMarket Sentiment Review & Weekly Hot Stock Watchlists - Newser
Historical volatility pattern of GRI Bio Inc. visualizedDay Trade & Fast Momentum Entry Tips - Newser
Will a bounce in Instil Bio Inc. offer an exit2025 Biggest Moves & AI Powered Buy and Sell Recommendations - Newser
TELA Bio Inc. stock momentum explainedJuly 2025 Patterns & Stock Market Timing Techniques - Newser
Understanding Instil Bio Inc.’s price movementMarket Growth Review & Safe Swing Trade Setups - Newser
Regression analysis insights on GRI Bio Inc. performanceJuly 2025 Review & Fast Gaining Stock Reports - Newser
How to forecast Passage Bio Inc. trends using time series2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - Newser
Smart tools for monitoring KALA BIO Inc.’s price actionAnalyst Upgrade & Proven Capital Preservation Tips - Newser
PAH Drug Developer Gossamer Bio Set for Key Presentations at Cantor, Wells Fargo, HC Wainwright Events - Stock Titan
Layoff Tracker: Exelixis Cuts Go Beyond Pennsylvania, Include 71 at California HQ - BioSpace
Is Nuvation Bio Inc. stock poised for growthJuly 2025 Breakouts & AI Optimized Trade Strategies - Newser
Trend analysis for Adicet Bio Inc. this weekBull Run & Stock Timing and Entry Methods - Newser
What candlestick patterns are forming on bluebird bio Inc.Stop Loss & Free AI Powered Buy and Sell Recommendations - Newser
What’s next for INmune Bio Inc. stock priceWeekly Trade Review & Entry Point Confirmation Signals - Newser
Genetic Medicines Pioneer Passage Bio to Showcase Neurodegenerative Disease Pipeline at Global Conference - Stock Titan
Visualizing Third Harmonic Bio Inc. stock with heatmaps2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Global Oncology Company Nuvation Bio Announces Triple Conference Schedule for September 2025 - Stock Titan
Is now a turning point for Adicet Bio Inc.Weekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser
Clinical-Stage Biotech Belite Bio Secures Speaking Slots at Three Premier Healthcare Conferences - Stock Titan
Live market analysis of Third Harmonic Bio Inc.2025 Market Trends & Scalable Portfolio Growth Methods - Newser
H.C. Wainwright Reiterates a Buy Rating on Nuvation Bio (NUVB) - MSN
Combining price and volume data for Nuvation Bio Inc.Dip Buying & Safe Swing Trade Setups - Newser
GRI Bio Inc. stock prediction for this weekQuarterly Trade Report & Daily Stock Trend Reports - Newser
Is Palisade Bio Inc. stock ready for a breakoutBear Alert & Low Drawdown Momentum Trade Ideas - Newser
Stop Loss: Is Upstream Bio Inc. forming a double bottomJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - theviewers.co.kr
Mustang Bio Inc. stock trend forecastJuly 2025 Summary & Verified Momentum Watchlists - Newser
Volume spikes in Palisade Bio Inc. stock – what they meanWeekly Market Outlook & Precise Swing Trade Alerts - Newser
Using economic indicators to assess Cabaletta Bio Inc. potentialWeekly Market Outlook & Low Volatility Stock Suggestions - Newser
Is Third Harmonic Bio Inc. building a consolidation baseJuly 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Heatmap analysis for Gossamer Bio Inc. and competitorsMarket Movers & Fast Exit Strategy with Risk Control - Newser
Combining price and volume data for Kronos Bio Inc.Rate Hike & Fast Momentum Stock Entry Tips - Newser
Regression analysis insights on Gossamer Bio Inc. performanceBreakout Watch & High Return Trade Guides - Newser
Sentiment Tools Show Shift in Trader Mood on Cabaletta Bio Inc.2025 Sector Review & Community Driven Trade Alerts - beatles.ru
Gossamer Bio Inc.’s Beta Climbs After Market VolatilityJuly 2025 Summary & High Yield Stock Recommendations - classian.co.kr
GRI Bio CEO to Showcase NKT Cell Therapy Pipeline at Webull Biotech Investor Event - Stock Titan
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Infinity Bio, Inc. Partners With the Austrian Institute of Technology to Provide Access to Antibody Reactome Profiling in Europe - Business Wire
Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire
Is Tourmaline Bio Inc. stock ready for a breakoutFree Alpha Driven Watchlist With Alerts - Newser
Belite Bio Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView
Korro Bio Inc expected to post a loss of $2.56 a shareEarnings Preview - TradingView
Annovis Bio Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
MUSTANG BIO, INC. SEC 10-Q Report - TradingView
REPEATTevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions - uk.finance.yahoo.com
KALA BIO Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Instil Bio Inc expected to post a loss of $2.50 a shareEarnings Preview - TradingView
KALA BIO, Inc. SEC 10-Q Report - TradingView
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts - The Globe and Mail
INmune Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
BioVie Inc. Announces Pricing of $12 Million Public Offering - The Manila Times
Gossamer Bio Expands Team with 168,750 Share Options Grant at $2.16 Exercise Price - Stock Titan
INmune Bio Inc. Announces Second Quarter 2025 Results, - GlobeNewswire
INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes - Stock Titan
Adicet Bio Clinical Trial Now Targets 6 Autoimmune Diseases as Company Streamlines for Growth - Stock Titan
Nuvation Bio Reports 1,043% YoY Sales Growth, Exceeds Revenue Estimates with $4.8 Million in GAAP Revenue - AInvest
Palisade Bio Reports 100% Clinical Response in Phase 1b - GlobeNewswire
Belite Bio Raises $15M in Strategic Financing with Potential for Additional $15M from Warrants - Stock Titan
4.10%
大文字化:
|
ボリューム (24 時間):